Total Voting Rights

RNS Number : 2742X
Eco Animal Health Group PLC
30 April 2021
 

30 April 2021

 

 

ECO Animal Health Group PLC

 

Total Voting Rights and Share Capital

 

 

ECO Animal Health Group PLC (the "Company") announces that, as at 30 April 2021, its issued share capital consists of 67,704,416 ordinary shares of 5 pence each with voting rights ('Ordinary Shares'). No Ordinary Shares are currently held in treasury and the voting rights of all the Ordinary Shares are identical.

 

The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company, under the FCA's Disclosure Guidance and Transparency Rules.

 

 

For further information, please contact:

 

 

ECO Animal Health Group plc

Marc Loomes (CEO)

Christopher Wilks (CFO)

 


020 8447 8899

 

IFC Advisory

Graham Herring

Zach Cohen

 

020 3934 6630

 

N+1 Singer (Nominated Adviser & Joint Broker)

Mark Taylor

Iqra Amin

 

020 7496 3000

Peel Hunt LLP (Joint Broker)

James Steel

Dr Christopher Golden

020 7418 8900

 

 

 

 

About ECO Animal Health

ECO Animal Health Group plc researches, develops and commercialises products for livestock. Our business strategy is to generate shareholder value by achieving the maximum sales potential from the existing product portfolio whilst investing in Research and Development for new products, particularly vaccines, and seeking to in-license new products.

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVREAALEDLSFEFA
UK 100

Latest directors dealings